Compare ANL & CRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ANL | CRT |
|---|---|---|
| Founded | 2004 | 1991 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | | Oil & Gas Production |
| Sector | | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.0M | 42.5M |
| IPO Year | 2023 | 1992 |
| Metric | ANL | CRT |
|---|---|---|
| Price | $1.38 | $8.52 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 10.1K | ★ 38.3K |
| Earning Date | 11-07-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.86% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.74 |
| Revenue | N/A | ★ $5,621,913.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.31 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.10 | $7.07 |
| 52 Week High | $2.99 | $13.31 |
| Indicator | ANL | CRT |
|---|---|---|
| Relative Strength Index (RSI) | 32.63 | 55.67 |
| Support Level | $1.32 | $8.29 |
| Resistance Level | $1.59 | $8.99 |
| Average True Range (ATR) | 0.14 | 0.21 |
| MACD | -0.01 | -0.06 |
| Stochastic Oscillator | 12.50 | 39.18 |
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
Cross Timbers Royalty Trust is a United States-based trust. The net profits interests are derived from producing royalty, overriding royalty interests, and working interest properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.